A Dipeptidyl Peptidase-4 Inhibitor, Des-Fluoro-Sitagliptin, Improves Endothelial Function and Reduces Atherosclerotic Lesion Formation in Apolipoprotein E

A Dipeptidyl Peptidase-4 Inhibitor, Des-Fluoro-Sitagliptin, Improves Endothelial Function and Reduces Atherosclerotic Lesion Formation in Apolipoprotein E–Deficient Mice

Published:2012-01 Issue:3 Volume:59 Page:265-276
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Matsubara Junichi,Sugiyama Seigo,Sugamura Koichi,Nakamura Taishi,Fujiwara Yukio,Akiyama Eiichi,Kurokawa Hirofumi,Nozaki Toshimitsu,Ohba Keisuke,Konishi Masaaki,Maeda Hirofumi,Izumiya Yasuhiro,Kaikita Koichi,Sumida Hitoshi,Jinnouchi Hideaki,Matsui Kunihiko,Kim-Mitsuyama Shokei,Takeya Motohiro,Ogawa Hisao

Funder

Ministry of Education, Science, and Culture of Japan

Merck & Company, Inc

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference17 articles.

1. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association;Buse;Circulation,2007

2. Effects of intensive glucose lowering in type 2 diabetes;Gerstein;N Engl J Med,2008

3. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes;Drucker;Lancet,2006

4. Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4;Arakawa;Diabetes,2010

5. Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease;Nystrom;Am J Physiol Endocrinol Metab,2004

Cited by 245 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting senescent cells in atherosclerosis: Pathways to novel therapies;Ageing Research Reviews;2024-11

2. The role of serine/threonine protein kinases in cardiovascular disease and potential therapeutic methods;Biomedicine & Pharmacotherapy;2024-08

3. Effect of tirzepatide on the progression of coronary atherosclerosis using MDCT: Rationale and design of the Tirzepatide treatment on coronary atherosclerosis progression: The (T-PLAQUE) randomized-controlled trial design;American Heart Journal;2024-08

4. Phloridzin's Diabetic Wound Healing Potential through DPP-4 Enzyme Inhibition: A Review Article;Current Diabetes Reviews;2024-04-26

5. Tacrolimus combined with arsenic trioxide provides a three-in-one drug-eluting coronary stent integrating anti-restenosis, pro-endothelialization and anti-inflammation;Medicine in Novel Technology and Devices;2024-03